Prasol Chemicals Limited IPO

Prasol Chemicals Limited IPO closed on 10 Sept 2026. Allotment 11 Sept 2026, listing 16 Sept 2026. Price band ₹643–₹676, lot 22 shares, GMP +₹0 (0%). Track allotment on Allotly.

About Prasol Chemicals Limited

Prasol Chemicals Limited is a specialty chemicals manufacturer incorporated in 1992. The company is involved in the manufacture of acetone-based, phosphorous-based and other specialty chemicals involving complex chemistries. Its product portfolio comprises over 150 specialty chemical products, including 21 acetone-based chemicals, 53 phosphorous-based chemicals and 76 other specialty products such as surfactants, performance additives, ethers, esters, polymers and acids. These products are used across performance chemicals, paints, inks, construction and adhesives, pharmaceuticals, agrochemicals, and home and personal care industries. The company manufactures products such as diacetone alcohol, isophorone, hexylene glycol, meta xylenol, phosphorous pentasulphide, phosphorous pentoxide, dithio-phosphates, polyphosphoric acid, DETC and phosphate esters. As of July 15, 2026, the company…

Strengths

• The company has a portfolio of over 150 specialty chemical products across acetone-based, phosphorous-based and other specialty chemicals. Its products are used across performance chemicals, paints, inks, construction and adhesives, pharmaceuticals, agrochemicals, and home and personal care.
• The company served 1,618 customers in FY2026, compared with 1,586 in FY2025 and 1,560 in FY2024. Repeat customers accounted for 93.28% of revenue from operations in FY2026, while its top 10 customers contributed 23.68% of revenue.
• The company is a Government of India certified 3 Star Export House and exported its products to 56 countries in FY2026. Its distribution network covers markets across Europe, Asia Pacific, the Americas, Africa, and the Middle East, with sales channel personnel in Shanghai and London and consignment stockists in Houston and Rotterdam.
• The company claims to have a dedicated R&D facility at its Khopoli manufacturing facility, equipped with a fluidised bed reactor, distillation column and centrifuge. It also claims to have pilot plants at both manufacturing facilities, while its in-house R&D team comprised 37 members as of June 30, 2026, including four PhD holders and 25 chemists.
• As of June 30, 2026, the company had a pipeline of 40 products at various stages of development, of which nine had cleared the pilot stage. It had also developed and commercialised 13 new products between April 1, 2023, and June 30, 2026.
• The company has been operating since 1992 and has more than three decades of experience in manufacturing acetone-based and phosphorous-based specialty chemicals. According to the CARE Report cited in the prospectus, it was the largest importer of acetone in India during calendar years 2023-2025 and among the top five users of yellow phosphorus in India during calendar years 2022-2025.
• Revenue from operations increased from Rs 876.56 crore in FY24 to Rs 1,012.49 crore in FY25 and Rs 1,232.59 crore in FY26. During the same period, PAT increased from Rs 18.13 crore to Rs 43.57 crore and Rs 83.12 crore, while the operating EBITDA margin improved from 6.91% to 11.30% during this period.

Risks

• The company’s net cash generated from operating activities declined from Rs 115.61 crore in FY24 to Rs 22.26 crore in FY25 and Rs 49.47 crore in FY26. The decline in FY26 was primarily due to an increase in trade and other receivables of Rs 81.68 crore and other current financial assets of Rs 12.90 crore, along with income tax payments of Rs 30.08 crore. In FY25, the decline was mainly due to an increase in trade and other receivables of Rs 37.41 crore and inventories of Rs 51.87 crore. Any significant fluctuation in operating cash flows or negative cash flow in the future could adversely affect the company’s growth prospects and financial condition.
• The company, its promoters, and directors are involved in certain outstanding legal proceedings that are currently pending. Any adverse outcome in any of these proceedings could hurt the company’s results of operations and financial condition.
• The company has contingent liabilities and commitments amounting to Rs 109.12 crore as of March 31, 2026, compared with Rs 46.81 crore as of March 31, 2025, and Rs 67.60 crore as of March 31, 2024, representing 24.33%, 12.74%, and 20.75% of its net worth, respectively. If a significant portion of these contingent liabilities and commitments materialises, it could adversely affect the company’s results of operations and financial condition.
• The company’s revenue is significantly dependent on acetone-based and phosphorous-based specialty chemicals, which contributed 42.75% and 38.30% of revenue from operations in FY26, amounting to Rs 526.89 crore and Rs 472.03 crore, respectively. Acetone-based specialty chemicals contributed 47.74% and 46.97% of revenue in FY25 and FY24, while phosphorous-based specialty chemicals contributed 34.47% and 31.82%, respectively. Any decline in demand for products in the industries served by the company, or the development of alternative formulations that substitute its products, could adversely affect its business, results of operations, cash flows and financial condition. Further, delays in developing and commercialising new products could increase the risk of existing products becoming obsolete.
• Customer defaults or delays in payments could adversely affect cash flows and financial performance. The company’s trade receivables increased from Rs 160.34 crore in FY24 to Rs 197.27 crore in FY25 and Rs 278.69 crore in FY26, representing 18.07%, 19.42% and 22.51% of total income, respectively. Trade receivable days stood at 68 days, 64 days, and 70 days during FY24, FY25, and FY26, respectively, while receivables written off due to non-payment amounted to Rs 0.27 crore, Rs 0.06 crore, and Rs 0.11 crore, respectively. Deterioration in customers’ creditworthiness, increase in receivable turnover days or significant defaults and delays in payments could adversely affect the company’s cash flows, results of operations and financial condition.
• The company’s labour-intensive operations are exposed to employee attrition, wage increases, and potential work stoppages. As of June 30, 2026, the employee attrition stood at 27.96% in FY26. Employee benefit expenses increased from Rs 32.83 crore in FY24 to Rs 41.70 crore in FY25 and Rs 50.37 crore in FY26, while labour charges increased from Rs 5.21 crore to Rs 7.40 crore and Rs 10.07 crore, respectively. Any shortage of skilled or unskilled workers, strikes, work stoppages, increased wage demands or defaults by contractors in making wage payments could disrupt operations, increase costs and adversely affect the company’s results of operations and financial condition.
• The company is dependent on certain key customers, and the loss of any of its top customers could adversely affect its financial performance. The top 10 customers contributed Rs 291.91 crore, Rs 222.31 crore and Rs 161.80 crore, representing 23.68%, 21.96% and 18.46% of revenue from operations in FY26, FY25, and FY24, respectively. If the company loses any of these key customers or faces a reduction or delay in orders from them, facility shutdowns, labour strikes, financial difficulties or other disruptions, the company’s business and financial condition could be adversely impacted.
• The company has significant outstanding borrowings, which may increase its financial and repayment obligations. As of July 15, 2026, the company had aggregate outstanding secured borrowings of Rs 343.67 crore. Any increase in borrowing costs, inability to service or refinance its debt, or restrictions on the availability of credit facilities could adversely affect the company’s cash flows, financial condition, and results of operations.

See all IPOs · Apply for your family on Allotly